NEW YORK – The Centers for Disease Control and Prevention on Thursday announced a new national genomics consortium to coordinate SARS-CoV-2 sequencing across the US.
The effort, called SPHERES (SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance), aims to monitor changes in the virus to support public health research and diagnostic and therapeutic development.